Report overview
This report aims to provide a comprehensive presentation of the global market for Investigational New Drug Contract Development and Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Investigational New Drug Contract Development and Manufacturing. This report contains market size and forecasts of Investigational New Drug Contract Development and Manufacturing in global, including the following market information:
Global Investigational New Drug Contract Development and Manufacturing Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Investigational New Drug Contract Development and Manufacturing market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Contract Development Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Investigational New Drug Contract Development and Manufacturing include Covance Inc., Charles River Laboratories Inc., Cambrex Corporation, IQVIA Holdings Inc., Syneos Health, Lonza, Catalent, Recipharm AB and Siegfried Holding AG, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
WE surveyed the Investigational New Drug Contract Development and Manufacturing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Investigational New Drug Contract Development and Manufacturing Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Investigational New Drug Contract Development and Manufacturing Market Segment Percentages, by Type, 2022 (%)
Contract Development
Contract Manufacturing
Global Investigational New Drug Contract Development and Manufacturing Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Investigational New Drug Contract Development and Manufacturing Market Segment Percentages, by Application, 2022 (%)
Pharmaceutical
Biotechnology
Others
Global Investigational New Drug Contract Development and Manufacturing Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Investigational New Drug Contract Development and Manufacturing Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Investigational New Drug Contract Development and Manufacturing revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Investigational New Drug Contract Development and Manufacturing revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Covance Inc.
Charles River Laboratories Inc.
Cambrex Corporation
IQVIA Holdings Inc.
Syneos Health
Lonza
Catalent
Recipharm AB
Siegfried Holding AG
Thermo Fisher Scientific Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Investigational New Drug Contract Development and Manufacturing, market overview.
Chapter 2: Global Investigational New Drug Contract Development and Manufacturing market size in revenue.
Chapter 3: Detailed analysis of Investigational New Drug Contract Development and Manufacturing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Investigational New Drug Contract Development and Manufacturing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
